Therapy Areas: Central Nervous System
18 May 2022 - Teva Pharmaceuticals, a U.S. affiliate of Israel-based Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced on Tuesday four data presentations for AUSTEDO(R) (deutetraben...
18 May 2022 - - Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) (TASE: TEVA) Teva Canada Ltd subsidiary of., welcomes the recently announced public formulary cove...
10 May 2022 - - Positive high-level results from the open-label Phase III CHAMPION-NMOSD trial showed that Ultomiris (ravulizumab-cwvz) achieved a statistically significant and clinically meaningful r...
4 May 2022 - - South Korea-based RNAi therapeutics developer OliX Pharmaceuticals, Inc. (KOSDAQ:226950) has identified effective inhibition of target gene expression in rodent brain tissues for i...
3 May 2022 - - US-based biopharmaceutical company Sage Therapeutics, Inc. (NASDAQ: SAGE) and US-based neuroscience specialist Biogen Inc. (NASDAQ: BIIB) have initiated a rolling submission of a New Dr...
3 May 2022 - - The European Commission has approved Uplizna (inebilizumab) as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin...
Related Headlines